All Cosmos Bio-Tech Holding Balance Sheet Health
Financial Health criteria checks 5/6
All Cosmos Bio-Tech Holding has a total shareholder equity of NT$2.8B and total debt of NT$533.2M, which brings its debt-to-equity ratio to 18.9%. Its total assets and total liabilities are NT$3.7B and NT$859.5M respectively. All Cosmos Bio-Tech Holding's EBIT is NT$189.9M making its interest coverage ratio -7.2. It has cash and short-term investments of NT$1.6B.
Key information
18.9%
Debt to equity ratio
NT$533.25m
Debt
| Interest coverage ratio | -7.2x |
| Cash | NT$1.57b |
| Equity | NT$2.81b |
| Total liabilities | NT$859.54m |
| Total assets | NT$3.67b |
Recent financial health updates
Recent updates
There May Be Reason For Hope In All Cosmos Bio-Tech Holding's (TWSE:4148) Disappointing Earnings
Mar 22
Is All Cosmos Bio-Tech Holding (TPE:4148) Using Too Much Debt?
Apr 20Returns On Capital At All Cosmos Bio-Tech Holding (TPE:4148) Paint An Interesting Picture
Jan 10
All Cosmos Bio-Tech Holding Corporation's (TPE:4148) Price Is Out Of Tune With Earnings
Dec 22Are Poor Financial Prospects Dragging Down All Cosmos Bio-Tech Holding Corporation (TPE:4148 Stock?
Dec 01Financial Position Analysis
Short Term Liabilities: 4148's short term assets (NT$2.8B) exceed its short term liabilities (NT$790.2M).
Long Term Liabilities: 4148's short term assets (NT$2.8B) exceed its long term liabilities (NT$69.3M).
Debt to Equity History and Analysis
Debt Level: 4148 has more cash than its total debt.
Reducing Debt: 4148's debt to equity ratio has increased from 7.6% to 18.9% over the past 5 years.
Debt Coverage: 4148's debt is well covered by operating cash flow (179.9%).
Interest Coverage: 4148 earns more interest than it pays, so coverage of interest payments is not a concern.